PT  - JOURNAL ARTICLE
AU  - Bawah, Abdul-Malik
AU  - Annan, Reginald A.
AU  - Ellahi, Basma
AU  - SanthanakrishnanVimaleswaran, Karani
AU  - Haadi, Abdul Rahman
TI  - Vitamin D status and cardiometabolic disease risk among healthy adults of Northern Ghana
AID  - 10.1101/2022.11.24.22282710
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.11.24.22282710
4099  - http://medrxiv.org/content/early/2022/11/28/2022.11.24.22282710.short
4100  - http://medrxiv.org/content/early/2022/11/28/2022.11.24.22282710.full
AB  - Cardiometabolic Disease (CMD) is a cluster of conditions that increase the risk for cardiovascular events, but its relationship with vitamin D status has not been studied in Ghana. A cross-sectional study design was conducted to investigate the relationship between serum vitamin D status and CMD risk (obesity, type 2 diabetes mellitus, hypertension, and dyslipidemia) among 302 apparently healthy adults, aged 25 to 59 and of northern decent in Ghana. Biochemical analysis was done to determine serum total cholesterol (TC), Triglycerides (TG), High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), Fasting Blood Glucose (FBG), Glycated Haemoglobin (HbA1c) and serum vitamin D levels of participants. Anthropometric assessment was also done and BMI, WC, HC, Blood Pressure, WHR, Body Fat (BF) and visceral fat percentages were obtained. Analysis was done using SPSS (version 25). We evaluated CMD risk factors to predict vitamin D status using binary and multiple linear logistics regression analysis. Similar between gender, participants’ mean age was 38.78years (SD 10.42years). The females had higher BMI (24.31 SD 7.96 versus 22.52 SD 3.07 kgm2, p=0.006), % total body fat (24.31 SD 7.96 versus 22.52 SD 3.07%, p=0.001), WC (24.31 SD 7.96 versus 22.52 SD 3.07 inches, p=0.002), and HC (24.31 SD 7.96 versus 22.52 SD 3.07, p=0.002 inches) than the males, while the males had higher mean total cholesterol (5.74 SD 1.02 versus 3.57 SD 1.02) and LDL (5.40 SD 1.05, verse 3.22 SD 1.09, p=0.005) than the females. Serum vitamin D levels was significantly associated with age (p= 0.047) but not gender (p=0.349). Overall, 6.4% of participants had CMD, representing 10.2% of the females, and no male. Multivariate analysis reveals gender, average BP, FBG, and % total body fat to significantly affect serum vitamin D concentrations. Seven percent (7%) of participants were serum vitamin D deficient (VDD) and 28.5% had serum vitamin D insufficiency (VDI), similar by gender, but increased with age (p=0.047). Both mean SBP (P<0.0001) and DBP (p<0.0001) increased with VDD, while means of FBS (p=0.032), BMI (p=0.004), HbA1c (p=0.040), and LDL (p=0.047) are highest in the VDD group and least in the Vitamin D Sufficient (VDS) group. Binary Logistic regression showed participants with high SBP (OR= 0.055; 95% CI= 0.008-0.361; p= 0.003) and high FBS (OR= 0.076; 95% CI= 0.014-0.404; p= 0.002) had increased odds of VDD compared with normal levels of SBP and FBS. Multiple logistics regression showed FBG, TG, LDL and WC significantly predicted CMD. In conclusion, CMD risk factors were common among the participants and more than a third were vitamin D deficient or insufficient. Individual CMD risk factors increased with vitamin D deficiency, but CMD did not predict serum vitamin D status.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPersonal funding as a PhD candidateAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Council for Scientific and Industrial Research (CSIR) Institutional Review Board (IRB) (Ref: RPN 003/CSIR-IRB/2018). In addition, this study was approved by the Metropolitan Director of Health Services, Tamale (TMHD/MPHs/09).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata will be provided later as per the policy